share_log

Spyre Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Peter Harwin(11.17%),Tomas Kiselak(11.17%), etc.

Spyre Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Peter Harwin(11.17%),Tomas Kiselak(11.17%), etc.

Spyre Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Peter Harwin(11.17%),Tomas Kiselak(11.17%)等
美股SEC公告 ·  04/25 16:41
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息